T cell receptor:peptide-major histocompatibility complex complex (TCR:pMHC complex)

The T cell receptor:peptide-major histocompatibility complex complex is a molecular assembly formed when a T cell receptor (TCR) expressed on the surface of a T lymphocyte binds to a specific antigenic peptide presented by a major histocompatibility complex (MHC) molecule on an antigen-presenting cell. This binding event is central to adaptive immunity, as it initiates T cell activation, leading to diverse immune responses including cytotoxicity, cytokine secretion, and immunological memory. The TCR recognizes both the MHC molecule and the bound peptide via its hypervariable complementarity-determining regions (CDRs), ensuring exquisite specificity. Structural and functional variations exist between classical αβ and γδ TCRs, as well as between MHC class I and class II presentation modes, but all involve highly specific protein-protein contacts and induce signal transduction via associated CD3 complex chains. The diversity of TCR:pMHC recognition underpins the immune system’s ability to discriminate self from non-self and is fundamental to the pathophysiology and treatment of infections, cancer, autoimmune disease, and other immune-mediated conditions[1][2][3][5][6][7].

Other names

TCR:pMHC complexTCR-MHC complexT-cell receptor:peptide-MHC complexT-cell receptor–major histocompatibility complex complex

TCR gene transfer: Introduces TCRs with desired specificity to redirect T cell responses Peptide-MHC binding modulation: Alters antigen presentation to elicit or suppress T cell activity Immune checkpoint blockade: Indirectly enhances or dampens TCR:pMHC signaling TCR mimic antibodies: Bind MHC-peptide complexes, mimicking TCR function